- Amgen scraps experimental weight loss pill, moves forward with injectionon May 2, 2024 at 10:59 pm
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
- Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take holdon May 2, 2024 at 8:00 pm
The company reiterated its full-year 2024 sales guidance of roughly $4 billion, which includes revenue from the expected launch of its RSV vaccine.
- UnitedHealth CEO estimates one-third of Americans could be impacted by Change Healthcare cyberattackon May 1, 2024 at 9:01 pm
UnitedHealth CEO estimates that data from one-third of Americans could have been compromised in the Change Healthcare cyberattack.
- UnitedHealth CEO tells lawmakers the company paid hackers a $22 million ransomon May 1, 2024 at 8:41 pm
Senators questioned UnitedHealth Group CEO Andrew Witty on Wednesday about a cyberattack on its subsidiary Change Healthcare.
- Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.on May 1, 2024 at 8:23 pm
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
- CVS shares plummet as health company slashes profit outlook on higher medical costson May 1, 2024 at 8:19 pm
CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.
- Pfizer beats earnings estimates, raises outlook on cost cuts and smaller-than-feared drop in Covid drug saleson May 1, 2024 at 8:18 pm
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral pill Paxlovid.
- Eli Lilly assures investors it can overcome the high-quality problem of too much demandon May 1, 2024 at 3:51 pm
The world's most valuable drugmaker hiked its full-year sales and profit guidance, despite missing lighter-than-expected first-quarter revenue.
- Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successorson May 1, 2024 at 1:31 pm
AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Group's CEO will testify on Capitol Hill.
- Cyberattack on UnitedHealth firm forces doctors to dig into personal savings to stay afloaton April 30, 2024 at 8:08 pm
Many doctors have been left without a way to get paid for their services.